Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for emergence agitation after photodynamic therapy in children with nevus flammeus
ChiCTR2400084394Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in port-wine stain, Emergence agitation (EA), postoperative pain and 1 more (3 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Emergence agitation. Planned start May 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
port-wine stainEmergence agitation (EA)postoperative painInsomnia
Beyond the preview
Go deeper on ChiCTR2400084394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084394.